319 related articles for article (PubMed ID: 32016703)
1. Cost-Effectiveness Analysis of Four Common Diagnostic Methods for Clostridioides difficile Infection.
Xuan S; Zangwill KM; Ni W; Ma J; Hay JW
J Gen Intern Med; 2020 Apr; 35(4):1102-1110. PubMed ID: 32016703
[TBL] [Abstract][Full Text] [Related]
2. Performance of laboratory tests for detection for Clostridioides difficile: A multicenter prospective study in Japan.
Senoh M; Kato H; Honda H; Fukuda T; Tagashira Y; Horiuchi H; Chiba H; Suzuki D; Hosokawa N; Kitazono H; Norisue Y; Kume H; Mori N; Morikawa H; Kashiwagura S; Higuchi A; Kato H; Nakamura M; Ishiguro S; Morita S; Ishikawa H; Watanabe T; Kojima K; Yokomaku I; Bando T; Toimoto K; Moriya K; Kasahara K; Kitada S; Ogawa J; Saito H; Tominaga H; Shimizu Y; Masumoto F; Tadera K; Yoshida J; Kikuchi T; Yoshikawa I; Watanabe T; Honda M; Yokote K; Toyokawa T; Miyazato H; Nakama M; Mahe C; Reske K; Olsen MA; Dubberke ER
Anaerobe; 2019 Dec; 60():102107. PubMed ID: 31647977
[TBL] [Abstract][Full Text] [Related]
3. Implementing a Clostridium difficile testing algorithm and its effect on isolation duration and treatment initiation: a pre- and post-implementation study.
Vogelzang EH; Lankelma JM; van Mansfeld R; van Prehn J; van Houdt R
Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1071-1076. PubMed ID: 31970532
[TBL] [Abstract][Full Text] [Related]
4. A 2-step algorithm combining glutamate dehydrogenase and nucleic acid amplification tests for the detection of Clostridioides difficile in stool specimens.
Liu C; Tang C; Han Y; Xu Y; Ni F; Jin K; Liu G
Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):345-351. PubMed ID: 32944896
[TBL] [Abstract][Full Text] [Related]
5. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
[TBL] [Abstract][Full Text] [Related]
6. A cost of illness comparison for toxigenic Clostridioides difficile diagnosis algorithms in developing countries.
Cançado GGL; Abreu ES; Nardelli MJ; Serwa P; Brachmann M
Anaerobe; 2021 Aug; 70():102390. PubMed ID: 34058377
[TBL] [Abstract][Full Text] [Related]
7. Comparing the economic and health benefits of different approaches to diagnosing Clostridium difficile infection.
Bartsch SM; Umscheid CA; Nachamkin I; Hamilton K; Lee BY
Clin Microbiol Infect; 2015 Jan; 21(1):77.e1-9. PubMed ID: 25636938
[TBL] [Abstract][Full Text] [Related]
8. Budget Impact Analysis of Adopting a One-Step Nucleic Acid Amplification Testing (NAAT) Alone Diagnostic Pathway for
Lim VW; Tomaru T; Chua B; Ma Y; Yanagihara K
Diagnostics (Basel); 2023 Apr; 13(8):. PubMed ID: 37189564
[No Abstract] [Full Text] [Related]
9. Can a toxin gene NAAT be used to predict toxin EIA and the severity of
Garvey MI; Bradley CW; Wilkinson MAC; Holden E
Antimicrob Resist Infect Control; 2017; 6():127. PubMed ID: 29270290
[TBL] [Abstract][Full Text] [Related]
10. Sequential introduction of a multistep testing algorithm and nucleic acid amplification testing leading to an increase in
Skinner AM; Yu B; Cheknis A; Pacheco SM; Gerding DN; Johnson S
Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1148-1153. PubMed ID: 32576334
[TBL] [Abstract][Full Text] [Related]
11. Impact of the introduction of nucleic acid amplification testing on Clostridioides difficile detection and ribotype distribution in Wales.
Perry MD; White PL; Morris TE
Anaerobe; 2021 Feb; 67():102313. PubMed ID: 33309680
[TBL] [Abstract][Full Text] [Related]
12. A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of
Kraft CS; Parrott JS; Cornish NE; Rubinstein ML; Weissfeld AS; McNult P; Nachamkin I; Humphries RM; Kirn TJ; Dien Bard J; Lutgring JD; Gullett JC; Bittencourt CE; Benson S; Bobenchik AM; Sautter RL; Baselski V; Atlas MC; Marlowe EM; Miller NS; Fischer M; Richter SS; Gilligan P; Snyder JW
Clin Microbiol Rev; 2019 Jun; 32(3):. PubMed ID: 31142497
[TBL] [Abstract][Full Text] [Related]
13. Superiority of the DNA amplification assay for the diagnosis of C. difficile infection: a clinical comparison of fecal tests.
Barkin JA; Nandi N; Miller N; Grace A; Barkin JS; Sussman DA
Dig Dis Sci; 2012 Oct; 57(10):2592-9. PubMed ID: 22576711
[TBL] [Abstract][Full Text] [Related]
14. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
Humphries RM; Uslan DZ; Rubin Z
J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of Treatment Regimens for Clostridioides difficile Infection: An Evaluation of the 2018 Infectious Diseases Society of America Guidelines.
Rajasingham R; Enns EA; Khoruts A; Vaughn BP
Clin Infect Dis; 2020 Feb; 70(5):754-762. PubMed ID: 31001619
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of a newly developed high-speed polymerase chain reaction analysis system for the diagnosis of Clostridioides difficile infection.
Furukawa K; Mitsutake H; Aso R; Sekizawa R; Okanda T; Hayashi K; Matsumoto T; Nakamura S
J Infect Chemother; 2021 May; 27(5):715-721. PubMed ID: 33402305
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in Japan.
Okumura H; Ueyama M; Shoji S; English M
J Infect Chemother; 2020 Jun; 26(6):611-618. PubMed ID: 32165072
[TBL] [Abstract][Full Text] [Related]
18. Clostridioides difficile Infection in Cancer and Immunocompromised Patients: Relevance of a Two-step Diagnostic Algorithm and Infecting Ribotypes on Clinical Outcomes.
Yepez Guevara EA; Aitken SL; Olvera AV; Carlin L; Fernandes KE; Bhatti MM; Garey KW; Adachi J; Okhuysen PC
Clin Infect Dis; 2021 May; 72(10):e460-e465. PubMed ID: 32803229
[TBL] [Abstract][Full Text] [Related]
19. Description of antibiotic treatment in adults tested for Clostridioides difficile infection: a single-center case-control study.
Kim MH; Kim YC; Kim JL; Park YS; Kim H
BMC Infect Dis; 2022 Jan; 22(1):104. PubMed ID: 35093016
[TBL] [Abstract][Full Text] [Related]
20. Two-step Testing for Clostridioides Difficile is Inadequate in Differentiating Infection From Colonization in Children.
Parnell JM; Fazili I; Bloch SC; Lacy DB; Garcia-Lopez VA; Bernard R; Skaar EP; Edwards KM; Nicholson MR
J Pediatr Gastroenterol Nutr; 2021 Mar; 72(3):378-383. PubMed ID: 32925555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
